dc.contributor.author
Cepas, Virginio
dc.contributor.author
López, Yuly
dc.contributor.author
Gabasa, Yaiza
dc.contributor.author
Martins, Clara B.
dc.contributor.author
Ferreira, Joana D.
dc.contributor.author
Correia, Maria J.
dc.contributor.author
Santos, Lília M. A.
dc.contributor.author
Oliveira, Flávio
dc.contributor.author
Ramos, Vitor
dc.contributor.author
Reis, Mariana
dc.contributor.author
Castelo-Branco, Raquel
dc.contributor.author
Morais, João
dc.contributor.author
Vasconcelos, Vitor
dc.contributor.author
Probert, Ian
dc.contributor.author
Guilloud, Emilie
dc.contributor.author
Mehiri, Mohamed
dc.contributor.author
Soto González, Sara M.
dc.date.issued
2019-07-09T10:23:26Z
dc.date.issued
2019-07-09T10:23:26Z
dc.date.issued
2019-06-12
dc.date.issued
2019-06-21T18:00:36Z
dc.identifier
https://hdl.handle.net/2445/136707
dc.description.abstract
Bacterial biofilms are complex biological systems that are difficult to eradicate at a medical,
industrial, or environmental level. Biofilms confer bacteria protection against external factors and
antimicrobial treatments. Taking into account that about 80% of human infections are caused by
bacterial biofilms, the eradication of these structures is a great priority. Biofilms are resistant to
old-generation antibiotics, which has led to the search for new antimicrobials from different sources,
including deep oceans/seas. In this study, 675 extracts obtained from 225 cyanobacteria and microalgae
species (11 phyla and 6 samples belonging to unknown group) were obtained from different culture
collections: The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC), the Coimbra
Collection of Algae (ACOI) from Portugal, and the Roscoff Culture Collection (RCC) from France.
The largest number of samples was made up of the microalgae phylum Chlorophyta (270) followed
by Cyanobacteria (261). To obtain a large range of new bioactive compounds, a method involving
three consecutive extractions (hexane, ethyl acetate, and methanol) was used. The antibiofilm
activity of extracts was determined against seven different bacterial species and two Candida strains
in terms of minimal biofilm inhibitory concentration (MBIC). The highest biofilm inhibition rates
(%) were achieved against Candida albicans and Enterobacter cloacae. Charophyta, Chlorophyta, and
Cyanobacteria were the most effective against all microorganisms. In particular, extracts of Cercozoa
phylum presented the lowest MBIC50 and MBIC90 values for all the strains except C. albicans.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: http://dx.doi.org/10.3390/antibiotics8020077
dc.relation
Antibiotics, 2019, vol. 8, num. 2
dc.relation
http://dx.doi.org/10.3390/antibiotics8020077
dc.relation
info:eu-repo/grantAgreement/EC/H2020/952374/EU//BlueBio4Future
dc.relation
info:eu-repo/grantAgreement/EC/H2020/634588/EU//NOMORFILM
dc.rights
cc by (c) Cepas et al., 2019
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.title
Inhibition of Bacterial and Fungal Biofilm Formation by 675 Extracts from Microalgae and Cyanobacteria
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion